A Review On : Herbal Anticancer Drug

Authors(5) :-Kiran P Patil, Omkar A Patil, Trupti D Dudhgaonkar, Shrinivas K Mohite, Chandrakant S Magdum

Cancer is major health problem in both developed developing countries. Cancer after cardiovascular disease is the second leading cause of death. Cancer is the abnormal growth of cells in our bodies that can lead to death. Plant-derived compounds have been an important source of several clinically useful anti-cancer agents. Plant have been the beacon of therapeutic sources for curing diseases from times immemorial. Medicinal plant with their isolated lead molecules are also used as an alternative medicine for treating cancer. These chemical compounds are formulated with a view to create effective drugs against cancer. Vincristine, Vinblastine, Homoharringtonine, Honokiol , Paclitaxel, Topotecan, Maytansine, Astraguoside , Docetaxel, Elliticine, Lapochel, Oleanolic acid, Cisplatin, Etoposide, Teniposide and Resveratrol this lead molecules isolated from different medicinal plants are in use to treat cancer and chemotherapeutic side effect. In the present review, an attempt has been made to study the plants that have been used in the treatment of cancer.

Authors and Affiliations

Kiran P Patil
Rajarambapu College of Pharmacy, Kasegaon, Walwa, Sangali, Maharashtra, India
Omkar A Patil
Rajarambapu College of Pharmacy, Kasegaon, Walwa, Sangali, Maharashtra, India
Trupti D Dudhgaonkar
Rajarambapu College of Pharmacy, Kasegaon, Walwa, Sangali, Maharashtra, India
Shrinivas K Mohite
Rajarambapu College of Pharmacy, Kasegaon, Walwa, Sangali, Maharashtra, India
Chandrakant S Magdum
Rajarambapu College of Pharmacy, Kasegaon, Walwa, Sangali, Maharashtra, India

Cancer, Anti Cancer Drugs, Vincristine, Paclitaxel

  1. Jordan, MA (January 2002). "Mechanism of action of antitumor drugs that interact with microtubules and tubulin.". Current medicinal chemistry. Anti-cancer agents 2 (1):1–17.Doi:10.2174/1568011023354290. PMID 12678749
  2. Jordan, M. A.; Leslie, W. (2004). "Microtubules as a Target for Anticancer Drugs". Nature Reviews Cancer 4 (4): 253–265. doi:10.1038/nrc1317. PMID 15057285
  3. A Passi Publication , DRUG INDEX, vol. 12 Number 4,2009 page no. 523.
  4. Yuji Maruyama and HisashiKuribara Department of Neuropsychopharmacology (Tsumura),Gunma University School of Medicine, Gunma, Japan.
  5. Aoki A, Kuribara H, Maruyama Y. Assessment of psychotropic effects of Saiboku-to by discrete shuttle avoidance in mice. Jpn J Neuropsychopharmacol1997; 19:357–364.
  6. Chiu JH, Ho CT, Wei YH, Lui WY, Hong CY. In vitro and in vivo protective effect of honokiol on rat liver from peroxidative injury. Life Sci1997; 61:1961–1971.
  7. Clark AM, Feraly FSE, Li WS. Antimicrobial activity of phenolic constituents of Magnolia grandifloraL. J Pharm Sci1981; 70:951–952.
  8. R P WarrellJr, C J Coonley and T S Gee© 1985 by American Society of Clinical Oncology Homoharringtonine: an effective new drug for remission induction in refractory nonlymphoblastic leukemia.JCO May 1985 vol. 3 no. 5 617-621.
  9. Overview of the Pharmacological Features of HonokiolYuji Maruyama and HisashiKuribaraDepartment of Neuropsychopharmacology (Tsumura), Gunma University School of Medicine, Gunma, Japan CNS Drug ReviewsVol. 6, No. 1, pp. 35–44
  10. Bristol-Myers Squibb Company Princeton, NJ 08543 USA *Cremophor® EL is the registered trademark of BASF Aktiengesellschaft. Cremophor® EL is further purified by a Bristol-Myers Squibb Company proprietary process before use. 53 Reference ID: Rev April 2011 dose
  11. Eric K. Rowinsky, MD Cancer Therapy and Research Center, Institute for Drug Development, 8122 Datapoint Drive, Suite 700, San Antonio, Texas 78229.
  12. Mfd. for SAGENT PharmaceuticalsSchaumburg, IL 60195Made in USA©2014 Sagent Pharmaceuticals, Inc.September 2014
  13. MAYTANSINE BINDING TO THE VINBLASTINE SITES OF TUBULIN B. BHATTACHARYYA+ and J. WOLFFNational Institute of Arthritis, Metabolism and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014, USA Received 4 January 1977 Volume 75, number I FEBS LETTERS March 1977
  14. Maytansine and Cellular Metabolites of Antibody- Maytansinoid Conjugates Strongly Suppress Microtubule Dynamics by Binding to Microtubules Manu Lopus1, Emin Oroudjev1, Leslie Wilson1, Sharon Wilhelm2, Wayne Widdison2, Ravi Chari2, and Mary Ann Jordan
  15. Jellin JM, Gregory PJ, Batz F, Hitchens K, et al. Pharmacist’s Letter/Prescriber’s Letter Natural Medicines Comprehensive Database. 4thed. Stockton, CA: Therapeutic Research Facility; 2002: p. 103-5.
  16. WHO monographs on selected medicinal plants. WHOwebsite. Available at: http://www.who.int/medicines/library/trm/medicinalplants/monographs.shtml. Accessed March 8, 2003.
  17. McKenna DJ, Hughes K and Jones K. Astragalus. AlternTher Health Med 2002 Nov/Dec; 8 (6) 34-40
  18. Samantha Dodd Reviewed 5/12/03 Susan Paulsen Pharm D
  19. National Institutes of Health U.S. Department of Health and Human Services Created May 2007 Updated April 2012-D384.
  20. Alberg AJ, Brock MV, Stuart JM. Epidemiology of lung cancer: Looking to the future. J ClinOncol. 2005; 23:3175–3185. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994; 330:1029-1035.
  21. American Cancer Society. CancerFacts & Figures 2016. Atlanta, Ga: American Cancer Society; 2016. American Cancer Society. Cancer Prevention & Early Detection Facts &Figures 2015- 2016. Atlanta, Ga: American Cancer Society; 2015. American Cancer Society. Cancer Treatment & Survivorship Facts & Figures 2014- 2015. Atlanta, Ga: American Cancer Society; 2015.
  22. DATA SHEET November 2013 Taxotere (1-Vial) –docetaxeln taxotere-1vial-ccdsv-28-dsv8-13nov13 page 1 to 45
  23. AquilurRahman*, JamesC. Cradock and J. Paul Davignon Article first published online: 21 SEP 2006 DOI: 10.1002/jps.2600670509 dose
  24. Biomed Pap Med FacUnivPalacky Olomouc Czech Repub. 2006, 150(1):13–23. 13 © M. Stiborova, M. Rupertova, H. H. Schmeiser, E. FreiMarie Stiborovaa, Martina Rupertovaa, Heinz H. Schmeiserb, Eva Freib a Department of Biochemistry, Faculty of Science, Charles University, Albertov 2030, 12840 Prague 2, Czech Republic b Division of Molecular Toxicology, German Cancer Research Center, ImNeuenheimer Feld 280, 69120 Heidelberg Germany e-mail: Received: April 4, 2006; Accepted: May 16, 2006.
  25. HidayatHussain,*a KarstenKrohn,aViqarUddinAhmad,bGhulam Abbas Miana,c and Ivan Robert GreendaDepartment of Chemistry, University of Paderborn, WarburgerStraße 100, 33098 Paderborn,GermanybH.E.J. Research Institute of Chemistry, International Center for Chemical and BiologicalSciences, University of Karachi, Karachi 75270, Pakistan.
  26. Lapachol as an epithelial tumor inhibitor agent in Drosophila melanogaster heterozygote for tumor suppressor gene wtsW.F. Costa1, A.B. Oliveira2 and J.C. Nepomuceno1,3 1Instituto de Genética e Bioquímica, Universidade Federal de Uberlândia, Uberlândia, MG, Brasil2Departamento de ProdutosFarmacêuticos, Faculdade de Farmácia, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brasil
  27. Oleanolic acid induces metabolic adaptation in cancer cells by activating the AMP-activated protein kinase pathway.Liu J1, Zheng L, Wu N, Ma L, Zhong J, Liu G, Lin X. Author information1Institute of Oceanology, Chinese Academy of Sciences , Qingdao 266071, China.
  28. DrYue-Yong Zhu, Liver Center, The First Affiliated Hospital of Fujian Medical University, 20 Chazhong Road, Fuzhou, Fujian 350005, P.R. China, Article notes Copyright and License information Received 2014 May 26; Accepted 2015 Mar 12.
  29. New York: Springer; 2010: 347–369. Anderson GL, Limacher M, Assaf AR, et al. Effects of conjugated equine estrogen in Postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004 Apr 14; 291(14):1701−1712.
  30. Data were provided by the Office for National Statistics on request, June 2012. Similar data can be found here: http:// www.ons.gov.uk/ons/search/index.html?n ewquery=cancer+registrations
  31. Data were provided by ISD Scotland on request, April 2012. Similar data can be found here: http://www.isdscotland. org/Health-Topics/Cancer/Publications/ index.asp etoposide.
  32. Hande KR (1998). "Etoposide: four decades of development of a topoisomerase II inhibitor". Eur.J.Cancer 34 (10):1514–21
  33. Longe JL (2002). Gale Encyclopedia Of Cancer: A Guide To Cancer And Its Treatments. Detroit: Thomson Gale. pp. 397–399. ISBN 978-1-4144-0362-5.Jump up^ Pommier Y, Leo E, Zhang H, Marchand C (2010). "DNA topoisomerases and their poisoning by anticancer and antibacterialdrugs".Chem.Biol. 17(5):421
  34. Gaver RC; Deeb G; “The effect of other drugs on the in vitro binding of 14C-etoposide to human serum proteins.” Proc Am Assoc Cancer Res; 30:A2132, 1989.
  35. Terverkrijging van de graad van doctor aan de Erasmus Universiteit Rotterdam opgezag van de Rector Magnificus Prof.dr.ir. J.H. van Bemmel en volgensbesluit van het College voorPromoties De openbareverded igingzalplaatsvindenop woensdag 29 October 2003 om 15.45 uur.
  36. Pacholec M, Bleasdale JE, Chrunyk B, Cunningham D, Flynn D, Garofalo RS, Griffith D, Griffor M, Loulakis P, Pabst B, Qiu X, Stockman B, Thanabal V, Varghese A, Ward J, Withka J, Ahn K; Bleasdale; Chrunyk; Cunningham; Flynn; Garofalo; Griffith; Griffor; Loulakis; Pabst; Qiu; Stockman; Thanabal; Varghese; Ward; Withka; Ahn (March 2010)."SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1". J. Biol. Chem. 285 (11): 8340 doi:10.1074/jbc.M109.088682. PMC 2832984.PMID 20061378.

Publication Details

Published in : Volume 2 | Issue 2 | March-April 2016
Date of Publication : 2016-04-30
License:  This work is licensed under a Creative Commons Attribution 4.0 International License.
Page(s) : 261-268
Manuscript Number : IJSRST162298
Publisher : Technoscience Academy

Print ISSN : 2395-6011, Online ISSN : 2395-602X

Cite This Article :

Kiran P Patil, Omkar A Patil, Trupti D Dudhgaonkar, Shrinivas K Mohite, Chandrakant S Magdum, " A Review On : Herbal Anticancer Drug", International Journal of Scientific Research in Science and Technology(IJSRST), Print ISSN : 2395-6011, Online ISSN : 2395-602X, Volume 2, Issue 2, pp.261-268, March-April-2016.
Journal URL : http://ijsrst.com/IJSRST162298

Article Preview